公开(公告)号：US20200371113A1

公开(公告)日：2020-11-26

申请号：US16636235

申请日：2018-08-06

Applicant: B.R.A.H.M.S GMBH ,  UNIVERSITAT HEIDELBERG

Inventor： Thorsten BRENNER ,  Markus Alexander WEIGAND ,  Florian UHLE ,  Darius Cameron WILSON

IPC: G01N33/68

Abstract: The invention relates to a method for the diagnosis and/or risk stratification of invasive fungal infections (IFI)/invasive fungal diseases (IFD) and in particular associated with sepsis or septic shock, wherein a determination of the marker proadrenomedullin (proADM) or a partial peptide or fragment thereof, in particular midregional proadrenomedullin (MR-proADM), or contained in a marker combination (panel, cluster), is carried out from a patient to be examined. Furthermore, the invention relates to a diagnostic assay and a kit for carrying out the method.